Arthritis & Rheumatology
Overview
Arthritis & Rheumatology is a peer-reviewed medical journal that focuses on the latest research and advancements in the field of rheumatology. It covers a wide range of topics related to arthritis, autoimmune diseases, musculoskeletal disorders, and their diagnosis, treatment, and management. The journal provides a platform for scientists, clinicians, and researchers to share their findings, promote collaboration, and contribute to the understanding and improvement of patient care in this specialized area of medicine.
Details
Details
Abbr.
Arthritis Rheumatol
Publisher
Wiley
Start
2014
End
Continuing
Frequency
Monthly
p-ISSN
2326-5191
e-ISSN
2326-5205
Country
United States
Language
English
Specialty
Rheumatology
Metrics
Metrics
h-index / Ranks: 119
353
SJR / Ranks: 415
3708
CiteScore / Ranks: 332
20.40
JIF / Ranks: 274
13.3
Recent Articles
1.
Jin Y, Cheng I, So H, Lai B, Ying S, Kwok K, et al.
Arthritis Rheumatol
. 2025 Mar;
PMID: 40083242
Objectives: This study aimed to ascertain the effect of secukinumab on erosion and enthesiophyte progression in psoriatic arthritis (PsA) by high-resolution peripheral quantitative computed tomography (HR-pQCT). Methods: This was a...
2.
Pisetsky D, Rogers J, Eudy A, Martucci K, Ji R, Lipsky P
Arthritis Rheumatol
. 2025 Mar;
PMID: 40065163
No abstract available.
3.
Trinh-Minh T, Tran-Manh C, Gyorfi A, Dickel N, Liebel C, Zhou X, et al.
Arthritis Rheumatol
. 2025 Mar;
PMID: 40064593
Objectives: Systemic sclerosis (SSc) is a connective tissue disease with fibrotic remodeling of the skin and various internal organs. SSc is associated with the highest case-specific mortality of all rheumatic...
4.
Di Matteo A, Di Donato S, Filippucci E
Arthritis Rheumatol
. 2025 Mar;
PMID: 40033171
No abstract available.
5.
Wheeler A, Baker J, Riley 4th T, Johnson T, Yang Y, Roul P, et al.
Arthritis Rheumatol
. 2025 Mar;
PMID: 40033001
Objective: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a significant cause of morbidity and mortality among patients with RA, yet effective risk stratification for RA-ILD is lacking. We sought to...
6.
Shen D, Jin D, Xu H, Cheng-Chung Wei J, Ying Z
Arthritis Rheumatol
. 2025 Mar;
PMID: 40028691
No abstract available.
7.
Sreekanth A, George J, Saijan S, Menon A, Shenoy D P, Ahmed S, et al.
Arthritis Rheumatol
. 2025 Mar;
PMID: 40026266
No abstract available.
8.
Ma J, Xu T, Zhu H, Chen X, Li L, Zhao Z, et al.
Arthritis Rheumatol
. 2025 Mar;
PMID: 40026078
Objective: Activated T cells play a pivotal pathogenic role in the progression of Sjögren's disease (SjD); however, there are currently no targeted therapies specifically designed to address them. This study...
9.
Wechsler M, Silver J, Wolff G, Price R, Verghis R, Weller P, et al.
Arthritis Rheumatol
. 2025 Feb;
PMID: 40008472
Objectives: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, relapsing, inflammatory disease. Management of EGPA predominantly relies on oral corticosteroids (OCS), which are associated with many adverse effects. The Phase...
10.
Alehashemi S, Buehring B, de Jesus A, Gaurav S, Rastegar A, Baumgardner A, et al.
Arthritis Rheumatol
. 2025 Feb;
PMID: 40007227
Objective: To report the efficacy and safety of interferon-β (IFNβ) neutralizing monoclonal antibody (dazukibart), followed by treatment with anti-IFNAR1 antibody (anifrolumab), in a patient with STING-associated vasculopathy with onset in...